Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical and economic outcomes associated with respiratory syncytial virus vaccination in older adults in the United States
Authors
Keywords
-
Journal
VACCINE
Volume 40, Issue 3, Pages 483-493
Publisher
Elsevier BV
Online
2021-12-20
DOI
10.1016/j.vaccine.2021.12.002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessment of the Effects of Active Immunisation against Respiratory Syncytial Virus (RSV) using Decision-Analytic Models: A Systematic Review with a Focus on Vaccination Strategies, Modelling Methods and Input Data
- (2021) Marina Treskova et al. PHARMACOECONOMICS
- Frailty Hinders Recovery From Influenza and Acute Respiratory Illness in Older Adults
- (2020) Caitlin Lees et al. JOURNAL OF INFECTIOUS DISEASES
- Evaluating the next generation of RSV intervention strategies: a mathematical modelling study and cost-effectiveness analysis
- (2020) David Hodgson et al. BMC Medicine
- Characteristics of hospitalized adult patients with laboratory documented Influenza A, B and Respiratory Syncytial Virus – A single center retrospective observational study
- (2019) Regev Cohen et al. PLoS One
- Cost-effectiveness of Palivizumab for Respiratory Syncytial Virus: A Systematic Review
- (2019) Stephen Mac et al. PEDIATRICS
- Healthcare resource use and economic burden attributable to respiratory syncytial virus in the United States: a claims database analysis
- (2018) Caroline Amand et al. BMC HEALTH SERVICES RESEARCH
- Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network)
- (2018) Michaela K. Nichols et al. VACCINE
- Severe Morbidity and Mortality Associated With Respiratory Syncytial Virus Versus Influenza Infection in Hospitalized Older Adults
- (2018) Bradley Ackerson et al. CLINICAL INFECTIOUS DISEASES
- Clinical Features, Severity, and Incidence of RSV Illness During 12 Consecutive Seasons in a Community Cohort of Adults ≥60 Years Old
- (2018) Edward A Belongia et al. Open Forum Infectious Diseases
- Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
- (2017) Louis Fries et al. Immunity & Ageing
- Hospitalizations for respiratory syncytial virus (RSV) among adults in the United States, 1997 - 2012
- (2017) Susan T. Pastula et al. Open Forum Infectious Diseases
- The epidemiology of medically attended respiratory syncytial virus in older adults in the United States: A systematic review
- (2017) Ann D. Colosia et al. PLoS One
- Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment
- (2016) Cameron Griffiths et al. CLINICAL MICROBIOLOGY REVIEWS
- Modeling The Economic Burden Of Adult Vaccine-Preventable Diseases In The United States
- (2016) Sachiko Ozawa et al. HEALTH AFFAIRS
- Vaccination strategies against respiratory syncytial virus
- (2016) Dan Yamin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Respiratory Syncytial Virus Infection in Older Adults: An Under-Recognized Problem
- (2015) Angela R. Branche et al. DRUGS & AGING
- Respiratory syncytial virus- and human metapneumovirus-associated emergency department and hospital burden in adults
- (2014) Kyle Widmer et al. Influenza and Other Respiratory Viruses
- Respiratory Syncytial Virus and Other Respiratory Viral Infections in Older Adults With Moderate to Severe Influenza-like Illness
- (2014) Ann R. Falsey et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
- (2014) Carlos A. DiazGranados et al. NEW ENGLAND JOURNAL OF MEDICINE
- Seasonal Incidence of Medically Attended Respiratory Syncytial Virus Infection in a Community Cohort of Adults ≥50 Years Old
- (2014) David L. McClure et al. PLoS One
- High Morbidity and Mortality in Adults Hospitalized for Respiratory Syncytial Virus Infections
- (2013) N. Lee et al. CLINICAL INFECTIOUS DISEASES
- A new simple primary care morbidity score predicted mortality and better explains between practice variations than the Charlson index
- (2013) Iain M. Carey et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- “How Much Will I Get Charged for This?” Patient Charges for Top Ten Diagnoses in the Emergency Department
- (2013) Nolan Caldwell et al. PLoS One
- RSV vaccine in development: Assessing the potential cost-effectiveness in the Dutch elderly population
- (2013) M.J. Meijboom et al. VACCINE
- Rates of Hospitalizations for Respiratory Syncytial Virus, Human Metapneumovirus, and Influenza Virus in Older Adults
- (2012) Kyle Widmer et al. JOURNAL OF INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search